A. Cavers Et Al. , "Behcet's disease risk-variant HLA-B51/ERAP1-Hap10 alters human CD8 T cell immunity," ANNALS OF THE RHEUMATIC DISEASES , vol.81, no.11, pp.1603-1611, 2022
Cavers, A. Et Al. 2022. Behcet's disease risk-variant HLA-B51/ERAP1-Hap10 alters human CD8 T cell immunity. ANNALS OF THE RHEUMATIC DISEASES , vol.81, no.11 , 1603-1611.
Cavers, A., Kugler, M. C., Ozguler, Y., Al-Obeidi, A. F., HATEMİ, G., Ueberheide, B. M., ... UÇAR, D.(2022). Behcet's disease risk-variant HLA-B51/ERAP1-Hap10 alters human CD8 T cell immunity. ANNALS OF THE RHEUMATIC DISEASES , vol.81, no.11, 1603-1611.
Cavers, Ann Et Al. "Behcet's disease risk-variant HLA-B51/ERAP1-Hap10 alters human CD8 T cell immunity," ANNALS OF THE RHEUMATIC DISEASES , vol.81, no.11, 1603-1611, 2022
Cavers, Ann Et Al. "Behcet's disease risk-variant HLA-B51/ERAP1-Hap10 alters human CD8 T cell immunity." ANNALS OF THE RHEUMATIC DISEASES , vol.81, no.11, pp.1603-1611, 2022
Cavers, A. Et Al. (2022) . "Behcet's disease risk-variant HLA-B51/ERAP1-Hap10 alters human CD8 T cell immunity." ANNALS OF THE RHEUMATIC DISEASES , vol.81, no.11, pp.1603-1611.
@article{article, author={Ann Cavers Et Al. }, title={Behcet's disease risk-variant HLA-B51/ERAP1-Hap10 alters human CD8 T cell immunity}, journal={ANNALS OF THE RHEUMATIC DISEASES}, year=2022, pages={1603-1611} }